PPARG and Insulin resistance: Meanwhile, GW9662 or PPARγ siRNA treatment significantly attenuated APL- induced insulin resistance improvement as evidenced by decrease of glucose uptake capability in palmitate -treated L6 myotubes (Fig 4G).